Industry trends suggest that vaccine research and development is an increasingly active component of healthcare business development. In recent years there has been a significant increase in vaccine partnering and M&A activity.

Read the full story

This month we provide you with an overview of deal analysis life science deal making activity, covering partnering, M&A and financing in January 2014 Read the full story

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in December 2013 Read the full story

Shares in Endocye more than doubled following the announcement of their entering a deal to develop its ovarian cancer drug with big pharma Merck & Co, jumping from $3.82 to $7.62 in a day Read the full story